AC
DBTX

Aaron Cowen’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Aaron Cowen’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-263,600
Closed -$801K – 107
2022
Q1 		$801K Hold
263,600
– – 0.02% 82
2021
Q4 		$1.23M Hold
263,600
– – 0.02% 86
2021
Q3 		$2.03M Hold
263,600
– – 0.03% 93
2021
Q2 		$2.27M Hold
263,600
– – 0.03% 108
2021
Q1 		$2.99M Buy
+263,600
New +$4.14M 0.04% 90

Other funds holding DBTX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Aaron Cowen's DBTX Position: Q2 2022 in Review

Aaron Cowen sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2022, closing a stake of 263,600 shares — an estimated $801K sold.

Aaron Cowen first reported a position in DBTX in Q1 2021 and held it in 5 quarters. The position peaked at $2.99M in Q1 2021. 42 funds tracked by Wall St. Rank hold DBTX as of Q2 2022.

  • Aaron Cowen reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Aaron Cowen sold 263,600 Decibel Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $801K.
  • Aaron Cowen first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Aaron Cowen's Decibel Therapeutics, Inc. Common Stock position peaked at $2.99M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Suvretta Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.